Cochrane · systematic review · CD013323
Non‐Chinese herbal medicines for functional dyspepsia
Báez, G, Vargas, C, Arancibia, M, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library
GutAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
12
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 8.3%Low 5 · 41.7%Moderate 6 · 50%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
STW5 (Iberogast) compared to placebo for functional dyspepsia
Population: participants with functional dyspepsia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Global symptoms of dyspepsia STW5 (Iberogast) vs placebo | no estimate extracted | 5 studies · 814 participants | Very low Downgraded: risk of bias, imprecision, inconsistency |
Global symptoms of dyspepsia (responders) STW5 (Iberogast) vs placebo | RR 1.55 [0.98, 2.47] | 2 studies · 324 participants | Low Downgraded: risk of bias, imprecision |
Adverse events Assessed clinically STW5 (Iberogast) vs placebo | RR 0.92 [0.52, 1.64] | 4 studies · 786 participants | Low Downgraded: risk of bias, imprecision |
Quality of life STW5 (Iberogast) vs placebo | no estimate extracted | 1 study · 52 participants | Low Downgraded: risk of bias, imprecision |
Peppermint/caraway oil compared to placebo for functional dyspepsia
Population: participants with functional dyspepsia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Global symptoms of dyspepsia Peppermint/caraway oil vs placebo | no estimate extracted | 2 studies · 210 participants | Moderate Downgraded: risk of bias |
Global symptoms of dyspepsia (responders) Peppermint/caraway oil vs placebo | RR 1.53 [1.3, 1.81] | 3 studies · 305 participants | Moderate Downgraded: risk of bias |
Adverse events Assessed clinically Peppermint/caraway oil vs placebo | RR 1.56 [0.69, 3.53] | 3 studies · 305 participants | Low Downgraded: risk of bias, imprecision |
Quality of life Peppermint/caraway oil vs placebo | no estimate extracted | 1 study · 99 participants | Moderate Downgraded: risk of bias |
Curcuma longa compared to placebo
Population: participants with functional dyspepsia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Global symptoms of dyspepsia Curcuma longa vs placebo | no estimate extracted | 2 studies · 110 participants | Moderate Downgraded: imprecision |
Global symptoms of dyspepsia (responders) Curcuma longa vs placebo | RR 1.5 [1.06, 2.11] | 1 study · 76 participants | Low Downgraded: risk of bias, imprecision |
Adverse events Assessed clinically Curcuma longa vs placebo | RR 1.26 [0.51, 3.08] | 1 study · 89 participants | Moderate Downgraded: imprecision |
Quality of life Curcuma longa vs placebo | no estimate extracted | 1 study · 89 participants | Moderate Downgraded: imprecision |